Atlas Trials

Phase 1 Study in Healthy Adults to See How Sevabertinib Changes Metformin Levels in the Body

Clinical trial NCT07753252 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07753252
Sponsor
Bayer
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2026-08-21
Primary completion
2026-09-21
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.